strong>Hyatt Regency San Francisco [
clear filter]
7:30am PST
7:30am PST
8:30am PST
Opening Remarks
Tuesday January 14, 2025 8:30am - 8:40am PST
Speakers 
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More →
8:40am PST
9:00am PST
Accelerating Pharmaceutical Processing Innovation Through Artificial Intelligence
Tuesday January 14, 2025 9:00am - 9:20am PST
Speakers 
Co-Founder & CEO, Phorum.AI
David Shrier is a serial entrepreneur and globally renowned advisor on digital acceleration. He has extensive technology innovation experience, having led $11 billion of growth initiatives and taken a company public on the NYSE. He runs venture studio Visionary Future, where he has...
Read More →
CEO, Veranova
Mike Riley joined Veranova as Chief Executive Officer in May 2023. Mike has over 25 years of professional experience, the majority of which has been spent in the pharmaceutical contract development and manufacturing (CDMO) industry. Prior to joining Veranova, he spent 19 years at...
Read More →
9:20am PST
Panel: Pharma’s Financial Landscape: Revenue Trends, M&A Strategies, and Patent Expirations
Tuesday January 14, 2025 9:20am - 10:00am PST
Moderators 
Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser...
Read More →
Chief Strategy Officer, Astellas
As Chief Strategy Officer of Astellas Pharma, Adam Pearson plays a pivotal role in shaping the company’s corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient...
Read More →
10:00am PST
10:30am PST
Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals
Tuesday January 14, 2025 10:30am - 10:50am PST
Speakers 
President of Radiology, Bayer Pharmaceuticals
Nelson Ambrogio, President Radiology at Bayer, is a global healthcare leader with a career spanning more than 25 years with Bayer. Before joining Radiology in the beginning of 2024, he has been leading the Oncology Franchise for Bayer Pharmaceuticals in the United States, overseeing...
Read More →
10:50am PST
11:10am PST
Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape
Tuesday January 14, 2025 11:10am - 12:00pm PST
Moderators
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More → IQ
Chief Medical Officer, Biohaven, Ltd
Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals
Eric A. Hughes, MD, PhD, is Executive Vice President, Global R&D and Chief Medical Officer at Teva, overseeing a global organization responsible for the discovery, development, registration, medical affairs and patient safety activities for Teva’s generics, biosimilar and innovative...
Read More →
Chief Development Officer, Atea Pharmaceuticals
Janet is an expert in virology with a proven track record in antiviral therapeutic drug discovery and development. Janet has more than 20 years of broad and deep pharmaceutical and biopharmaceutical experience including clinical development program leadership and responsibilities...
Read More →
12:00pm PST
12:20pm PST
1:20pm PST
Panel: Our AI future: A Sector-by-Sector Breakdown
Tuesday January 14, 2025 1:20pm - 2:00pm PST
Moderators 
Staff Writer, Fierce Pharma
Zoey Becker is a staff writer for Fierce Pharma. She joined the Fierce team in 2022 after interning at the Cincinnati Herald. Zoey is a graduate of Miami University, where she earned a degree in journalism as well as sociology. She currently resides in Chicago with her two goldfi...
Read More →
Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D
Sai Jasti is Head of Data Science and AI for Bayer Pharma R&D. In this capacity, Sai is responsible for driving Digital, Data and Analytics for Pharma R&D. He is passionate about helping scientists discover transformative medicines faster and driving innovation using Machine learning...
Read More →
Envisagenics, CEO and Co-Founder
Dr. Maria Luisa Pineda is the CEO and co-founder of Envisagenics. Dr. Pineda embarked on her career in STEM as a high school Intel International Science Fair winner in Miami after immigrating from Colombia in 2001. She received her doctorate from Cold Spring Harbor Laboratory School...
Read More →
Senior Vice President, Digital Science & Innovation, Novo Nordisk A/S
Lars has held his current role since early 2022 and is responsible for accelerating the digital transformation of R&ED and driving scientific innovation beyond the limits of human cognition through the purpose of DSI.A long-time employee of Novo Nordisk, Lars has held a variety of...
Read More →
2:00pm PST
2:20pm PST
2:40pm PST
3:10pm PST
3:30pm PST
3:50pm PST
The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies
Tuesday January 14, 2025 3:50pm - 4:30pm PST
Moderators 
Deputy Editor, Fierce Pharma
Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a...
Read More →
President of the Global Oncology Business Unit and a member of the Executive Team, Takeda
Teresa Bitetti is President of the Global Oncology Business Unit and a member of the Executive Team at Takeda, where she oversees a global portfolio of therapies targeting gastrointestinal, thoracic, and hematological cancers. In this role, Teresa leads all aspects of Takeda’s multi-billion-dollar...
Read More →
Senior Vice President, Global Head Oncology, Research & Development, GSK
Hesham Abdullah is a seasoned physician-scientist who uniquely combines a clinician’s understanding of the impact cancer has on patients with deep expertise in identifying transformational opportunities to improve cancer treatment and care.As the head of GSK’s global oncology...
Read More →
Senior Vice President, Biologics Engineering & Oncology Targeted Delivery, AstraZeneca
I serve as Vice President, Tumour Targeted Delivery, Early Oncology. In my current role, I lead the research group dedicated to the discovery and preclinical development of targeted cancer therapeutics and novel delivery mechanisms that selectively attack cancer cells while sparing...
Read More →
Founder and Chief Executive Officer, IO Biotech
Dr. Zocca brings more than 20 years of experience in the biotechnology field and has founded and co-founded several biotech spinouts. Her focus on translational and clinical immune oncology has led to the development of important investigational immunotherapies for a variety of cancer...
Read More →
President & Chief Executive Officer, Xencor
Bassil Dahiyat has been Xencor’s president and chief executive officer since the Company’s incorporation in August 1997. He is the co-founder of Xencor and co-inventor of Xencor’s breakthrough XmAb® technology. He has led the Company in creating a diverse clinical-stage portfolio...
Read More →
4:30pm PST
4:50pm PST
Closing Remarks
Tuesday January 14, 2025 4:50pm - 5:00pm PST
Speakers
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More →
5:00pm PST
8:00am PST
8:00am PST
8:50am PST
Opening Remarks
Wednesday January 15, 2025 8:50am - 9:00am PST
Speakers
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More →
9:00am PST
9:20am PST
9:50am PST
Panel: Biotech Markets and IPOs: Trends from 2024 and Projections for 2025
Wednesday January 15, 2025 9:50am - 10:30am PST
Moderators 
Associate Editor, Fierce Biotech
Gabrielle Masson is an associate editor for Fierce Biotech. Prior to Fierce, she worked at Becker's Hospital Review, where she reported on public health and the pandemic. Gabrielle graduated from the University of Wisconsin-Madison after studying creative writing and criminal justice...
Read More →
Chief Executive Officer and Co-Founder, Septerna
Jeffrey Finer, MD, PhD, is the Chief Executive Officer and Co-Founder at Septerna. Dr. Finer has more than 35 years of research, clinical and business experience. He has focused his career on breakthrough innovations that have included moving several first-in-class drugs into clinical...
Read More →
Executive Director, Morgan Stanley
General Partner, Sofinnova Investments
CFO, Rapport Therapeutics
Troy has nearly two decades of financial leadership experience in the biotech and pharmaceuticals sectors. Over the course of his career, Troy has raised an impressive $4 billion-plus in capital for life science companies. Most recently, he was Chief Financial Officer at Karuna Therapeutics...
Read More →
10:30am PST
11:00am PST
11:20am PST
11:40am PST
Panel: Unlocking the Power of Healthcare Data: Advancing Access and Connectivity to Drive Patient Outcomes
Wednesday January 15, 2025 11:40am - 12:20pm PST
Moderators
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More → 
SVP, Data Sciences, Roche
Jeff is a Senior Vice President in PD Data Sciences (formerly Biometrics) at Roche. Data Sciences at Roche includes statisticians, patient-centered outcomes researchers, statistical programmers, clinical data managers, and medical data and information solution teams. Jeff is a member...
Read More →
12:20pm PST
1:20pm PST
Panel: End of the Conglomerate Era
Wednesday January 15, 2025 1:20pm - 2:00pm PST
Moderators 
FierceMedTech, Senior Editor
Conor Hale is a senior editor writing for FierceMedTech and FierceBiotech. He has previously covered the pharmaceutical and medical research industries in the Washington, D.C., area for The Cancer Letter and FDAnews. Conor graduated from St. Bonaventure University’s journalism school...
Read More →
Senior Vice President, Chief Administrative Officer, Zimmer Biomet
Rachel Ellingson was appointed Senior Vice President, Chief Administrative Officer in June 2024. In her role, she is responsible for strategy, business development (M&A execution and integration, strategic partnerships, divestitures and minority investments), marketing and communications...
Read More →GB
SVP, Global Marketing & Product Management, embecta
Americas Life Sciences Leader, Ernst & Young LLP
Arda Ural, PhD is the EY Americas Life Sciences Sector Leader. In this role, he is in service to EY life sciences professionals in North and South America, helping them to solve our clients’ most pressing issues at the C-suite level, building a sector community and upholding the...
Read More →
Chief Strategy Officer, GE HealthCare
Brian leads Strategy for GE HealthCare, responsible for accelerating GE HealthCare’s strategic goals and leading the business development function.Immediately prior to his appointment, Brian was the acting Chief Financial Officer of GE HealthCare from June 2020 after serving as...
Read More →
2:00pm PST
2:20pm PST
2:40pm PST
Panel: Cell & Gene Therapy: Challenges, Trends and Technologies
Wednesday January 15, 2025 2:40pm - 3:20pm PST
Moderators
Staff Writer, Fierce Pharma
Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser...
Read More → 
President, Nkarta
Dr. Nadir Mahmood serves as President of Nkarta, where he is responsible for driving the company’s strategic focus, business excellence, and technical success. He previously served as the Chief Executive Officer of Rezo Therapeutics, a private-stage drug discovery company. Prior...
Read More →
SVP, Primary Focus Lead Genetic Regulation, Astellas
Richard Wilson, Senior Vice President, Primary Focus Lead of Genetic Regulation at Astellas Gene Therapies, is responsible for setting and leading the gene therapy strategy for Astellas’ Primary Focus Genetic Regulation. Richard joined Astellas Gene Therapies (formerly Audentes...
Read More →
Chief Scientific Officer, Head of Research, Takeda
Based at Takeda’s Cambridge, Massachusetts, R&D campus, Christopher Arendt is responsible for oversight of Takeda’s Research and Early Development portfolio across Takeda’s core therapeutic areas of Gastroenterology andInflammation, Oncology, and Neuroscience. Prior to his...
Read More →
Executive Vice President, Kite, a Gilead Company
Cindy Perettie serves as Executive Vice President of Kite, a Gilead Company, and is responsible for overseeing the cell therapy business. Cindy joined Kite in 2023 with more than 20 years of scientific and commercial leadership experience in global biopharmaceutical organizations...
Read More →
3:20pm PST
Closing Remarks
Wednesday January 15, 2025 3:20pm - 3:30pm PST
Speakers
Senior Conference Production Director, Fierce Life Sciences
Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life...
Read More →
